Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001178913-21-000858
Filing Date
2021-03-02
Accepted
2021-03-02 06:14:53
Documents
2
Group Members
AMOON GENERAL PARTNER LTD.AMOON GROWTH FUND G.P. LIMITED PARTNERSHIPAMOON GROWTH FUND LIMITED PARTNERSHIPAMOON-VRCT SPV LIMITED PARTNERSHIP

Document Format Files

Seq Description Document Type Size
1 SC 13D zk2125689.htm SC 13D 123037
2 EXHIBIT 4 exhibit_4.htm EX-99 11976
  Complete submission text file 0001178913-21-000858.txt   136645
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Subject) CIK: 0001061027 (see all company filings)

EIN.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-81034 | Film No.: 21701222
SIC: 2834 Pharmaceutical Preparations

Mailing Address YERUSHALAYIM ROAD 34 BEIT GAMLA ENTRANCE B RA'ANANA L3 4350110
Business Address
Schindel Yair Chaim (Filed by) CIK: 0001823758 (see all company filings)

Type: SC 13D